Komori
Other Disclosures4886ASKA Pharmaceutical Holdings Co.,Ltd.Pharmaceuticals

ASKA Pharmaceutical Holdings Co.,Ltd. selected for the first time for “Sustainability Disclosures Showing Significant Improvement” chosen by GPIF domestic equity managers

ASKA Pharmaceutical Holdings Co.,Ltd. was selected for the first time for “Sustainability Disclosures Showing Significant Improvement” by GPIF’s domestic equity managers.

Worth reading
52Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Announced details

Integrated report “ASKA HD REPORT” and sustainability information disclosure
Applicable field (uses covered by this announcement)

Sustainability information disclosure concerning material issues for companies

Relationship between the counterparty and the company
ASKA Pharmaceutical Holdings Co.,Ltd.4886
Relationship with the Company

GPIF’s domestic equity managers evaluated and selected the company’s sustainability disclosures

CounterpartyDomestic equity investment managers of the Government Pension Investment Fund (GPIF)

GPIF is an independent administrative agency that manages and invests public pension reserves. Its domestic equity managers are investment managers selected by GPIF. Other information on the location, representative, capital, and year of establishment is Not disclosed

Award/certification name

“Sustainability Disclosure with Significant Improvement” from the perspective of materiality

Awarding / certifying body

GPIF’s domestic equity investment managers

In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.

Source (materials cited by the company)

GPIF, “Sustainability Disclosures Selected by GPIF’s Domestic Equity Managers: ‘Outstanding Sustainability Disclosures from the Perspective of Materiality’ and ‘Sustainability Disclosures Showing Significant Improvement’”; ASKA Pharmaceutical Holdings Co.,Ltd., integrated report “ASKA HD REPORT 2025”

Announced details
ItemDetails
Names of Products / Services CoveredIntegrated report “ASKA HD REPORT” and sustainability information disclosure
CounterpartyDomestic equity investment managers of the Government Pension Investment Fund (GPIF)
Counterparty overviewGPIF is an independent administrative agency that manages and invests public pension reserves. Its domestic equity managers are investment managers selected by GPIF. Other information on the location, representative, capital, and year of establishment is Not disclosed
Relationship with the CompanyGPIF’s domestic equity managers evaluated and selected the company’s sustainability disclosures
Applicable areaSustainability information disclosure concerning material issues for companies
Award/certification name“Sustainability Disclosure with Significant Improvement” from the perspective of materiality
Awarding / certifying bodyGPIF’s domestic equity investment managers
SourceGPIF, “Sustainability Disclosures Selected by GPIF’s Domestic Equity Managers: ‘Outstanding Sustainability Disclosures from the Perspective of Materiality’ and ‘Sustainability Disclosures Showing Significant Improvement’”; ASKA Pharmaceutical Holdings Co.,Ltd., integrated report “ASKA HD REPORT 2025”
Items this document does not state (10)
Contract ValueOffering priceContract DateLaunch dateRegistration number and expiry dateLocationLocation scaleQuantitative EffectsUsage historyImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The qualitative improvement in sustainability information disclosure, including the integrated report “ASKA HD REPORT,” was recognized.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
ASKA Pharmaceutical Holdings Co.,Ltd. selected for the first time for “Sustainability Disclosures Showing Significant Improvement” chosen by GPIF domestic equity managers | ASKA Pharmaceutical Holdings Co.,Ltd. (4886) timely disclosure | Komori